Understanding Chronic Treatments by Patients Over 65 Years of Age

NCT07241299 | Recruiting

• 1 other identifier: 2025_RIPH_02_ordonnance
• Study Type: observational
• Target: 150
• Locations: 1 country
• Sites: 2

Brief Summary

The ageing of the French population is accompanied by an increase in the number of chronic conditions per person. In 2008, according to IRDES (Institute for Research and Documentation in Health Economics), the average number of reported illnesses was six for people over the age of 65. This multi-morbidity is associated with polypharmacy, which is a recognised risk factor for poor treatment compliance. One of the causes of poor compliance is a lack of understanding of the treatment. In this context, the role of the general practitioner is central. General practitioners are responsible for more than three-quarters of medical prescriptions. They are the ones who initiate first-line treatments for chronic diseases, but also the ones who renew treatments introduced by specialists.

Conditions

Chronic Treatments

Keywords

chronic treatments; patients over 65 years

Outcome Measures

Primary Outcomes (1)

• Understanding each chronic treatment listed on the prescription

  A complete understanding of each chronic treatment, defined by knowledge of the dosage (number of doses and timing) and the indication for chronic treatment

  Day 0

Interventions

data collection OTHER

Data collection

Eligibility Criteria

• Age: 65 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients aged over 65, not living in a care home, with a prescription containing at least one medicine prescribed as part of their chronic treatment, defined as lasting more than 3 months, and agreeing to participate in the study.

You may qualify if:

• Are aged 65 or over
• Consulting one of the general practitioners agreeing to participate in the study
• Have a prescription containing at least one chronic treatment (defined as a treatment lasting more than 3 months)
• Agree to participate in the study.

You may not qualify if:

• Does not understand French,
• Has neurocognitive disorders
• Lives in a medical facility
• Consulting for an acute condition and whose prescription does not include chronic treatment.
• Protected by law (guardianship, curatorship, judicial protection),

Sponsors & Collaborators

• Université de Reims Champagne-Ardenne: lead

Study Sites (2)

Gestonnairedu CURRS

Reims, Université de Reims Champagne-Ardenne, 51100, France

RECRUITING

Ufr Medecine Urca

Reims, 51100, France

RECRUITING

MeSH Terms

Interventions

Data Collection

Intervention Hierarchy (Ancestors)

Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Central Study Contacts

Gestonnairedu CURRS

CONTACT

0326918822; currs@univ-reims.fr

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 14, 2025
• First Posted: November 21, 2025
• Study Start: November 17, 2025
• Primary Completion: November 17, 2025
• Study Completion (Estimated): September 5, 2026
• Last Updated: November 21, 2025

Record last verified: 2025-10

Locations

FR (2)